• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮质基底节综合征伴或不伴淀粉样蛋白生物标志物的临床表型。

Clinical Phenotypes in Corticobasal Syndrome with or without Amyloidosis Biomarkers.

机构信息

Department of Neurology and Neuropsychology, and CMMR PACA Ouest, CHU Timone, Assistance Publique-Hôpitaux de Marseille, Marseille, France.

Department of Nuclear Medecine, CHU Timone, Assistance Publique-Hôpitaux de Marseille, Marseille, France.

出版信息

J Alzheimers Dis. 2020;74(1):331-343. doi: 10.3233/JAD-190961.

DOI:10.3233/JAD-190961
PMID:32039846
Abstract

Corticobasal syndrome (CBS) is a neuropathologically heterogeneous entity. The use of cerebrospinal fluid and amyloid biomarkers enables detection of underlying Alzheimer's disease (AD) pathology. We thus compared clinical, eye movement, and 18FDG-PET imaging characteristics in CBS in two groups of patients divided according to their amyloid biomarkers profile. Fourteen patients presenting with CBS and amyloidosis (CBS-A+) were compared with 16 CBS patients without amyloidosis (CBS-A-). The two groups showed similar motor abnormalities (parkinsonism, dystonia) and global cognitive functions. Unlike CBS-A+ patients who displayed more posterior cortical abnormalities, CBS-A- patients demonstrated more anterior cortical and brain stem dysfunctions on the basis of neuropsychological testing, study of saccade velocities and brain hypometabolism areas on 18FDG-PET. Interestingly, Dopamine Transporter SPECT imaging showed similar levels of dopaminergic degeneration in both groups. These findings confirm common and distinct brain abnormalities between the different neurodegenerative diseases that result in CBS. We demonstrate the importance of a multidisciplinary approach to improve diagnosis in vivo in particular on oculomotor examination.

摘要

皮质基底节综合征(CBS)是一种神经病理学异质性实体。脑脊液和淀粉样蛋白生物标志物的使用可以检测到潜在的阿尔茨海默病(AD)病理学。因此,我们根据淀粉样蛋白生物标志物的特征将两组 CBS 患者的临床、眼球运动和 18FDG-PET 成像特征进行了比较。14 例皮质基底节综合征合并淀粉样蛋白阳性(CBS-A+)的患者与 16 例皮质基底节综合征合并淀粉样蛋白阴性(CBS-A-)的患者进行了比较。两组患者的运动异常(帕金森病、肌张力障碍)和整体认知功能相似。与 CBS-A+患者表现出更多的后部皮质异常不同,CBS-A-患者在神经心理学测试、扫视速度研究和 18FDG-PET 显示的脑代谢低下区域上表现出更多的前皮质和脑干功能障碍。有趣的是,多巴胺转运蛋白 SPECT 成像显示两组患者的多巴胺能退化水平相似。这些发现证实了导致 CBS 的不同神经退行性疾病之间存在共同和不同的大脑异常。我们证明了多学科方法的重要性,特别是在眼动检查方面,可以提高体内诊断的准确性。

相似文献

1
Clinical Phenotypes in Corticobasal Syndrome with or without Amyloidosis Biomarkers.皮质基底节综合征伴或不伴淀粉样蛋白生物标志物的临床表型。
J Alzheimers Dis. 2020;74(1):331-343. doi: 10.3233/JAD-190961.
2
Dopamine transporter SPECT imaging in corticobasal syndrome: A peak into the underlying pathology?皮质基底节综合征的多巴胺转运体 SPECT 成像:窥探潜在的病理变化?
Acta Neurol Scand. 2022 Jun;145(6):762-769. doi: 10.1111/ane.13614. Epub 2022 Mar 20.
3
CSF Alzheimer's disease-like pattern in corticobasal syndrome: evidence for a distinct disorder.皮质基底节综合征中类似阿尔茨海默病的脑脊液模式:一种独特疾病的证据。
J Neurol Neurosurg Psychiatry. 2011 Aug;82(8):834-8. doi: 10.1136/jnnp.2010.221853. Epub 2011 Feb 22.
4
Individual Brain Metabolic Signatures in Corticobasal Syndrome.皮质基底节综合征的个体大脑代谢特征。
J Alzheimers Dis. 2020;76(2):517-528. doi: 10.3233/JAD-200153.
5
FDG-PET Patterns Predict Amyloid Deposition and Clinical Profile in Corticobasal Syndrome.氟代脱氧葡萄糖正电子发射断层扫描(FDG-PET)模式可预测皮质基底节综合征中的淀粉样蛋白沉积及临床特征。
Mov Disord. 2021 Mar;36(3):651-661. doi: 10.1002/mds.28373. Epub 2020 Nov 18.
6
Clinical, neuropsychological and imaging characteristics of Alzheimer's disease patients presenting as corticobasal syndrome.阿尔茨海默病患者以皮质基底节综合征为表现的临床、神经心理学和影像学特征。
J Neurol Sci. 2019 Mar 15;398:142-147. doi: 10.1016/j.jns.2019.01.046. Epub 2019 Jan 29.
7
Diagnosing Corticobasal Syndrome Based on the Presence of Visual Hallucinations and Imaging with Amyloid Positron Emission Tomography.基于视幻觉的存在及淀粉样蛋白正电子发射断层扫描成像诊断皮质基底节综合征
Intern Med. 2018 Feb 15;57(4):605-611. doi: 10.2169/internalmedicine.8534-16. Epub 2017 Dec 21.
8
Imaging Biomarkers of Neurodegeneration in Alzheimer's Disease: Distinct Contributions of Cortical MRI Atrophy and FDG-PET Hypometabolism.阿尔茨海默病神经退行性变的影像学生物标志物:皮质 MRI 萎缩和 FDG-PET 低代谢的不同贡献。
J Alzheimers Dis. 2018;65(4):1147-1157. doi: 10.3233/JAD-180292.
9
Alzheimer's disease and corticobasal degeneration presenting as corticobasal syndrome.表现为皮质基底节综合征的阿尔茨海默病和皮质基底节变性。
Mov Disord. 2009 Jul 15;24(9):1375-9. doi: 10.1002/mds.22574.
10
Validity of cingulate-precuneus-temporo-parietal hypometabolism for single-subject diagnosis of biomarker-proven atypical variants of Alzheimer's Disease.扣带回-顶下小叶-颞顶叶代谢低下对生物标志物证实的阿尔茨海默病非典型变异的单病例诊断的有效性。
J Neurol. 2022 Aug;269(8):4440-4451. doi: 10.1007/s00415-022-11086-y. Epub 2022 Mar 26.

引用本文的文献

1
Relationships between PET and blood plasma biomarkers in corticobasal syndrome.皮质基底节综合征中 PET 与血浆生物标志物的关系。
Alzheimers Dement. 2024 Jul;20(7):4765-4774. doi: 10.1002/alz.13914. Epub 2024 Jun 17.
2
Multiomics Blood-Based Biomarkers Predict Alzheimer's Predementia with High Specificity in a Multicentric Cohort Study.多组学生物标志物在一项多中心队列研究中以高特异性预测阿尔茨海默病前驱期。
J Prev Alzheimers Dis. 2024;11(3):567-581. doi: 10.14283/jpad.2024.34.
3
Neuropathological hints from CSF and serum biomarkers in corticobasal syndrome (CBS): a systematic review.
皮质基底节综合征(CBS)中脑脊液和血清生物标志物的神经病理学提示:一项系统综述。
Neurol Res Pract. 2024 Jan 4;6(1):1. doi: 10.1186/s42466-023-00294-0.
4
Biological Diagnosis of Alzheimer's Disease Based on Amyloid Status: An Illustration of Confirmation Bias in Medical Research?基于淀粉样蛋白状态的阿尔茨海默病的生物学诊断:医学研究中确认偏倚的例证?
Int J Mol Sci. 2023 Dec 16;24(24):17544. doi: 10.3390/ijms242417544.
5
[F]-FDopa positron emission tomography imaging in corticobasal syndrome.皮质基底节综合征的[F]-FDopa 正电子发射断层扫描成像。
Brain Imaging Behav. 2023 Dec;17(6):619-627. doi: 10.1007/s11682-023-00789-z. Epub 2023 Jul 21.
6
Dysfunction of the glutamatergic photoreceptor synapse in the P301S mouse model of tauopathy.tau 病 P301S 小鼠模型中谷氨酸能光受体突触功能障碍。
Acta Neuropathol Commun. 2023 Jan 11;11(1):5. doi: 10.1186/s40478-022-01489-3.
7
Blood based biomarkers for movement disorders.用于运动障碍的基于血液的生物标志物。
Acta Neurol Scand. 2022 Oct;146(4):353-361. doi: 10.1111/ane.13700.
8
The Significance of Asymmetry in the Assessment of Brain Perfusion in Atypical Tauopathic Parkinsonian Syndromes.不对称性在非典型tau蛋白病帕金森综合征脑灌注评估中的意义
Diagnostics (Basel). 2022 Jul 9;12(7):1671. doi: 10.3390/diagnostics12071671.
9
From Cerebrospinal Fluid Neurochemistry to Clinical Diagnosis of Alzheimer's Disease in the Era of Anti-Amyloid Treatments. Report of Four Patients.从脑脊液神经化学到抗淀粉样蛋白治疗时代的阿尔茨海默病临床诊断。4例患者报告。
Biomedicines. 2021 Oct 2;9(10):1376. doi: 10.3390/biomedicines9101376.
10
Metabolic and Structural Signatures of Speech and Language Impairment in Corticobasal Syndrome: A Multimodal PET/MRI Study.皮质基底节综合征中言语和语言障碍的代谢与结构特征:一项多模态PET/MRI研究
Front Neurol. 2021 Aug 30;12:702052. doi: 10.3389/fneur.2021.702052. eCollection 2021.